Precursor T-lymphoblastic leukemia

Precursor T-lymphoblastic leukemia (also known as T-cell acute lymphoblastic leukemia and T-ALL) is a type of acute lymphoblastic leukemia that affects T cells. It is a rare form of cancer that primarily affects children and young adults.

Overview

Precursor T-lymphoblastic leukemia is a subtype of acute lymphoblastic leukemia, a cancer of the white blood cells. It is characterized by the overproduction of immature T cells, or T lymphoblasts. These immature cells can crowd out normal cells in the bone marrow, leading to a variety of symptoms.

Symptoms

The symptoms of precursor T-lymphoblastic leukemia can vary, but may include fatigue, fever, weight loss, and night sweats. Other symptoms can include bone pain, lymphadenopathy, and hepatosplenomegaly.

Diagnosis

Diagnosis of precursor T-lymphoblastic leukemia typically involves a bone marrow biopsy to examine the cells under a microscope. Other tests may include blood tests, imaging tests, and genetic testing.

Treatment

Treatment for precursor T-lymphoblastic leukemia typically involves chemotherapy, with the goal of achieving remission. In some cases, a stem cell transplant may be recommended.

Prognosis

The prognosis for precursor T-lymphoblastic leukemia can vary depending on a number of factors, including the patient's age and overall health, the stage of the disease, and the response to treatment.

See also

• Acute lymphoblastic leukemia
• T cell
• Leukemia

Precursor T-lymphoblastic leukemia Resources
Most recent articles Ongoing trials	Wikipedia